Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús San Miguel

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 2, 2009
Characteristics, pathogenesis, and novel treatments for multiple myelomaJesús San Miguel
Current Hematologic Malignancy Reports|February 25, 2011
Treatment of newly diagnosed myeloma in patients not eligible for transplantationM Victoria Mateos, Jesús San-Miguel
Data in Brief|June 1, 2017
Chorological maps for the main European woody speciesGiovanni Caudullo, Erik Welk, Jesús San-Miguel-Ayanz
The Science of the Total Environment|March 19, 2013
Estimating future burned areas under changing climate in the EU-Mediterranean countriesGiuseppe Amatulli, Andrea Camia, Jesús San-Miguel-Ayanz
Scientific Data|January 6, 2017
EU-Forest, a high-resolution tree occurrence dataset for EuropeAchille Mauri, Giovanni Strona, Jesús San-Miguel-Ayanz
Cancers|March 25, 2022
Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora's Box of Multiple MyelomaJuan-José Garcés, Jesús San-Miguel, Bruno Paiva
Plos One|March 20, 2015
Deregulation of DNA double-strand break repair in multiple myeloma: implications for genome stabilityAna B Herrero, Jesús San Miguel, Norma C Gutierrez
Acta Haematologica|September 17, 2005
Analysis of methylation pattern in multiple myelomaJesús San-Miguel, Ramón García-Sanz, Ricardo López-Pérez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2008
Individualizing treatment of patients with myeloma in the era of novel agentsJesús San-Miguel, Jean-Luc Harousseau, Douglas Joshua, et al.
British Journal of Haematology|December 11, 2007
Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?María-Victoria Mateos, Ramón García-Sanz, Enrique Colado, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Journal of the National Comprehensive Cancer Network : JNCCN|October 2, 2009
Characteristics, pathogenesis, and novel treatments for multiple myelomaJesús San Miguel
Current Hematologic Malignancy Reports|February 25, 2011
Treatment of newly diagnosed myeloma in patients not eligible for transplantationM Victoria Mateos, Jesús San-Miguel
Data in Brief|June 1, 2017
Chorological maps for the main European woody speciesGiovanni Caudullo, Erik Welk, Jesús San-Miguel-Ayanz
The Science of the Total Environment|March 19, 2013
Estimating future burned areas under changing climate in the EU-Mediterranean countriesGiuseppe Amatulli, Andrea Camia, Jesús San-Miguel-Ayanz
Scientific Data|January 6, 2017
EU-Forest, a high-resolution tree occurrence dataset for EuropeAchille Mauri, Giovanni Strona, Jesús San-Miguel-Ayanz
Cancers|March 25, 2022
Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora's Box of Multiple MyelomaJuan-José Garcés, Jesús San-Miguel, Bruno Paiva
Plos One|March 20, 2015
Deregulation of DNA double-strand break repair in multiple myeloma: implications for genome stabilityAna B Herrero, Jesús San Miguel, Norma C Gutierrez
Acta Haematologica|September 17, 2005
Analysis of methylation pattern in multiple myelomaJesús San-Miguel, Ramón García-Sanz, Ricardo López-Pérez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2008
Individualizing treatment of patients with myeloma in the era of novel agentsJesús San-Miguel, Jean-Luc Harousseau, Douglas Joshua, et al.
British Journal of Haematology|December 11, 2007
Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?María-Victoria Mateos, Ramón García-Sanz, Enrique Colado, et al.
Pageof 11